|
Mechanismfactor IX stimulants |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date29 Apr 2015 |
Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Celtic Pharmaceutical Holdings LP
0 Patents (Medical) associated with Celtic Pharmaceutical Holdings LP
100 Deals associated with Celtic Pharmaceutical Holdings LP
100 Translational Medicine associated with Celtic Pharmaceutical Holdings LP